Twitter Facebook YouTube Google+ LinkedIn RSS Feed


Test for Diagnosing Fibrolamellar Carcinoma Yields 100-Percent Accuracy

Mayo Clinic researchers recently developed an RT-PCR assay along with a break-apart FISH assay that can diagnose fibrolamellar carcinoma 100 percent of the time. The assays can detect the novel fusion at the transcriptional and genomic level, respectively.

Read this story

Recent Stories for Research

Other Posts for Research